Who Generates Higher Gross Profit? Pharming Group N.V. or Perrigo Company plc

Perrigo vs. Pharming: A Decade of Gross Profit Insights

__timestampPerrigo Company plcPharming Group N.V.
Wednesday, January 1, 2014144770000021595165
Thursday, January 1, 201517124000006590427
Friday, January 1, 2016205180000011768542
Sunday, January 1, 2017197950000092587038
Monday, January 1, 20181831500000129203843
Tuesday, January 1, 20191773300000165412447
Wednesday, January 1, 20201815200000203056430
Friday, January 1, 20211416200000169670071
Saturday, January 1, 20221455400000188060000
Sunday, January 1, 20231680400000220104000
Loading chart...

Unlocking the unknown

A Tale of Two Companies: Pharming Group N.V. vs. Perrigo Company plc

In the competitive landscape of the pharmaceutical industry, gross profit is a key indicator of a company's financial health. Over the past decade, Perrigo Company plc has consistently outperformed Pharming Group N.V. in terms of gross profit. From 2014 to 2023, Perrigo's gross profit averaged around $1.7 billion annually, peaking in 2016 with a remarkable $2.05 billion. In contrast, Pharming Group N.V. has shown a steady growth trajectory, with its gross profit increasing from a modest $6.6 million in 2015 to an impressive $220 million in 2023. This represents a staggering growth of over 3,200% for Pharming Group N.V. during this period. While Perrigo maintains a strong lead, Pharming's rapid growth highlights its potential to become a formidable player in the industry. Investors and industry watchers should keep an eye on these trends as they unfold.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025